Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Binding of Thrombin to Glycoprotein Ib Accelerates the Hydrolysis of Par-1 on Intact Platelets
2001
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
2023 StandoutNobel
Impact of protein-protein contacts on the conformation of thrombin-bound hirudin studied by comparison with the nuclear magnetic resonance solution structure of hirudin(1–51)
1992 StandoutNobel
Thrombin: a paradigm for enzymes allosterically activated by monovalent cations
2004
Pneumonectomy due to lung cancer results in a more pronounced activation of coagulation system than lobectomy
2009
A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds
2007 Standout
Hemoglobin disorders and endothelial cell interactions
2009
Molecular mechanisms of thrombin function
1997
Functionality map analysis of the active site cleft of human thrombin
1996 StandoutNobel
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Actin polymerisation regulates thrombin-evoked Ca2+signalling after activation of PAR-4 but not PAR-1 in human platelets
2006
Thrombin as procoagulant and anticoagulant
2007
Pulmonary Arterial Hypertension in Previously Splenectomized Patients with β-Thalassemic Disorders
2003
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Thrombin-induced platelet activation via PAR4: pivotal role for exosite II
2014 StandoutNobel
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
1999 Standout
Hemostatic Abnormalities and Liver Diseases
2008
Platelets and acute cerebral infarction
2012 StandoutNobel
Clinical classification of pulmonary hypertension
2004 Standout
The molecular basis of blood coagulation
1988 Standout
Effects of prolactin on platelet activation and blood clotting
2013 StandoutNobel
Snakebite envenoming
2017 Standout
PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation
2006
Vascular disorders of the liver # †
2008 Standout
Receptor-targeting mechanisms of pain-causing toxins: How ow?
2012 StandoutNobel
The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days
2008 StandoutNobel
A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain
2011 StandoutNatureNobel
Role of red blood cells in thrombosis
1999
The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships
1992
PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease‐activated receptor‐1 but not protease‐activated receptor‐4 in human platelets
2011
Mechanisms of brain injury after intracerebral haemorrhage
2005 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in precapillary pulmonary arterioles
2020
Effect of gamma radiation on the in vitro aggregability of WBC‐reduced apheresis platelets
2001
Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome
2000
Platelets in inflammation and atherogenesis
2005 Standout
Nuclear magnetic resonance solution structure of hirudin(1–51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain
1992 StandoutNobel
Sickle-cell disease
2010 Standout
Frequent factor II G20210A mutation in idiopathic portal vein thrombosis
1999
Polyphosphate binds with high affinity to exosite II of thrombin
2009
Snake venoms and the hemostatic system
1998
Differential activation and inhibition of human platelet thrombin receptors by structurally distinct α-, β- and γ-thrombin
2004
Protein complexes in snake venom
2009
A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy
2003 StandoutNobel
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Computation of Conformational Coupling in Allosteric Proteins
2009 StandoutNobel
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Characterisation of species differences in the platelet ADP and thrombin response
2005 StandoutNobel
Selection of single-stranded DNA molecules that bind and inhibit human thrombin
1992 StandoutNature
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage
2005 Standout
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
A player of many parts: The spotlight falls on thrombin's structure
1993
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
1998 Standout
Comparison of Enzyme Immunoassays for Detection of Antibodies to Hepatitis D Virus in Serum
2016
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development
2007 StandoutNobel
The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.
1989 Nobel
Platelet Degranulation Is Associated With Progression of Intima-Media Thickness of the Common Carotid Artery in Patients With Diabetes Mellitus Type 2
2005
Mechanism Of Action Of Vitamin K: Synthesis Of Y-Carboxyglutamic Aci
1980
Hyperresponsiveness of platelets in ischemic stroke
2007
Hemostatic Alterations in Sickle Cell Disease: Relationships to Disease Pathophysiology
2001
Changes in Surface Expression of Platelet Membrane Glycoproteins and Progression of Heart Transplant Vasculopathy
2000
Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273.
1986
Anticoagulant Properties of the Vascular Endothelium
1997
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
1996 Standout
Comparative Analysis of Haemostatic Proteinases: Structural Aspects of Thrombin, Factor Xa, Factor IXa and Protein C
1997
Course of Platelet Activation and Platelet-Leukocyte Interaction in Cerebrovascular Ischemia
2006
Thrombin-Induced Platelet Activation Is Inhibited by High- and Low-Molecular-Weight Heparin
1999
Guidelines for Infection Control in Dental Health Care Settings
2013 Standout
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.
1995 Nobel
Thrombin Interacts with Thrombomodulin, Protein C, and Thrombin-activatable Fibrinolysis Inhibitor via Specific and Distinct Domains
1999
Crystal structures of thrombin and thrombin complexes as a framework for antithrombotic drug design
1994
Protease-activated receptors in hemostasis
2016
Anophelin: Kinetics and Mechanism of Thrombin Inhibition
1999
Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets
2010
Prothrombin Frankfurt: A Dysfunctional Prothrombin Characterized by Substitution of Glu-466 by Ala
1995
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
α-Keto Amide Peptides: A Synthetic Strategy to Resin-Bound Peptide Isosteres for Protease Inhibitor Screening on Solid Support
2004 StandoutNobel
Marine Polysaccharides from Algae with Potential Biomedical Applications
2015 Standout
Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis
2009
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Identification of Glycyrrhizin as a Thrombin Inhibitor
1997
Delta hepatitis: molecular biology and clinical and epidemiological features
1993
The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1
2002
The Vascular Endothelium and Human Diseases
2013 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Protease-Activated Receptors: Contribution to Physiology and Disease
2004
Physiology of Microglia
2011 Standout
Modulation of Procarboxypeptidase R (ProCPR) Activation by Complementary Peptides to Thrombomodulin
2003 StandoutNobel
Works of M.C. Guillin being referenced
In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia major
1997
A chronic hypercoagulable state in patients with β‐thalassaemia major is already present in childhood
1999
Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity
1992
Covalent binding of human thrombin to a human endothelial cell-associated protein
1989
Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP
2003
Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: Characterization and mechanism of thrombin inhibition
1993
Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system
1995
Prothrombin madrid : A new familial abnormality of prothrombin
1979
Prothrombin Salakta : An abnormal prothrombin characterized by a defect in the active site of thrombin
1984
Identification of a prothrombin derivative in human urine
1978
Enzymic and nonenzymic properties of human beta-thrombin.
1988
Hypercoagulability after partial liver resection
2007
Evaluation of five hepatitis delta virus marker assays for detection of antigen and antibody
1989